PIL filed against illegal drug trials

The Supreme Court of India today admitted a Public Interest Litigation (PIL) regarding the alleged illegal clinical trials that were conducted on adults, children and mentally ill patients across the country. The PIL was triggered by the recent news reports that found illegal and unethical drug trials were conducted on mentally challenged patients at the M G M Medical College in MP.

Bristol-Myers, J&J Collaborate to Study Combination Therapy for Hepatitis C

Bristol-Myers Squibb Co. will collaborate with a unit of Johnson & Johnson to study a potential combination therapy for chronic hepatitis C.

The companies will study a regimen that combines Johnson & Johnson's drug TMC435 with Bristol-Myers Squibb's daclatasvir. The clinical trial of the drug cocktail will begin in the first half of 2012. It will include a combination of the two drugs, the drugs plus pegylated interferon and ribavirin, and the drugs plus ribavirin.

Sanofi Reports Positive Results of Lixisenatide Combination Therapy

Sanofi has announced the positive results from a Phase III GetGoal Duo 1study, that will assess the efficacy and safety of lixisenatide (Lyxumia) with Lantus (insulin glargine) in patients with Type 2 diabetes. Lixisenatide is an investigational once-daily GLP-1 peptide agonist, found to suppress glucagon secretion from pancreatic alpha cells and enhance insulin secretion by pancreatic beta cells.

Pfizer Takes First in Covario Study on SEO Health of Pharmaceutical Industry

Covario, Inc., the nation's largest independent provider of global search marketing agency services and technology solutions for search engine optimization, issued a white paper from a study on the SEO health of the world's leading pharmaceutical companies.